SABM President’s Award

Jacques Lacroix is professor, Department of Pediatrics, Université de Montréal. He is the director of the Clinician Investigator Program, Université de Montréal. His main topics of research are transfusion medicine, multiple organ dysfunction syndrome and pediatric trauma. He wrote 231 papers in peer-reviewed journals (h-index, 53; 11498 citations), 93 chapters, a textbook in pediatric critical care medicine, and 274 abstracts, posters and free papers. He gave 284 invited lectures across the world, including 150 outside Canada. He received more than $53 millions from academic granting agencies. He is the chairman of a research group on transfusion medicine in pediatrics. He completed two large randomized controlled trials, the TRIPICU study (N Engl J Med 2007;356:1609-19) and the ABLE study (N Engl J Med 2015;372:110-8), and he is presently conducting the ABC-PICU trials (NCT01977547) with Marisa Tucci and Phil Spinella. Many international organizations have sought his expertise (American NIH, British NIH, Société de réanimation de langue française, Society of Critical Care Medicine, etc.).

John Freedman, MD is a Professor Emeritus of Medicine and of Laboratory Medicine at the University of Toronto. He was Director of Transfusion Medicine at St. Michael’s Hospital, where he also supervised the aphaeresis unit and cellular immunology lab. His major research interest is in the field of platelet immunology and he has published almost 300 papers in scientific literature. He sits on many local and national committees and, in keeping with his interest in better blood utilization, is responsible for the development and direction of the provincial blood conservation ONTraC program of Ontario Transfusion Coordinators.

Richard Weiskopf is Professor Emeritus, University of California, San Francisco.

He received his M.D. from the Albert Einstein College of Medicine, completed his internship at the Beth Israel Hospital, Boston, and his residency in Anesthesia at the University of California, San Francisco and research fellowship in pulmonary physiology at the Cardiovascular Research Institute of UCSF. He then became a faculty member of the Peter Bent Brigham Hospital and Harvard Medical School before returning to UCSF. He was an employee of Novo Nordisk A/S (Denmark) 2005-07, directing the world-wide clinical development program in hemostasis.

His research interests have focused on oxygen transport and delivery, anemia, transfusion, and hemostasis. He has had many years of continuous NIH research funding., and is an author of many publications and numerous editorials. He was an editor of Anesthesiology for a decade, has served on NIH, FDA, DOD, and societal committees and panels. He has been a visiting professor at many institutions. Dr. Weiskopf consults for medical education companies, pharmaceutical and medical device companies, and several U.S. Governmental organizations.

Dr. Goodnough received his medical degree in 1975 from the University of Pennsylvania, completed an internship and residency at the University of Alabama, and a fellowship in hematology/oncology at Case Western Reserve University. He is board certified in internal medicine, hematology, oncology, and has an American College of Pathology Certification in Blood Banking.

As a visiting professor and frequent lecturer, he has presented his work in transfusion medicine at more than 150 national and international medical centers and scientific symposia. Dr. Goodnough has contributed more than 550 articles, abstracts, and book chapters to the medical literature on blood and blood products. He has developed a particular interest in the rational use of blood products, including the perioperative arena. His work has been published in The New England Journal of Medicine, Transfusion, Blood, Journal of Clinical Apheresis, Journal of the American College of Surgeons, and the American Journal of Clinical Pathology, among other professional peer-reviewed publications. He has been honored with membership in the Central Society for Clinical Research and is a past recipient of the National Institutes of Health Transfusion Medicine Academic Award and the American Heart Association Clinician-Scientist Award.

Early involvement in 1982 in the care of patients without blood transfusion led to both a lifelong interest for Doctor Spence and his development of one of the first bloodless medicine and surgery centers in the world.

He has devoted much of his clinical work to the advancement of blood management. He has been recognized both nationally and internationally for his work and is a sought-after speaker. He is the author of over 250 publications in these areas. Recently he co-authored the article Can Intravenous Iron Therapy Meet the Unmet Needs Created by the New Restrictions On Erythropoietic Stimulating Agents? which was published in Transfusion and is currently available online as a CME.

He is the only surgeon to have been awarded a Transfusion Medicine Academic Award grant from the National Institutes of Health.

He chaired the committee responsible for the development of surgical transfusion guidelines that were published in 1995 in the American Journal of Surgery. He has contributed chapters on transfusion and surgery to several major surgical and transfusion textbooks. He co-edited the 2nd edition of Perioperative Transfusion Medicine, a leading text in the field.

He was founding member of SABM and served as its first president. He is a founding board member of the Medical Society for Blood Management.

Dr. Adamson completed his undergraduate work at the University of California, Berkeley, and received his MD from the University of California, Los Angeles. Trained in internal medicine and hematology at the University of Washington, he became head of the Division of Hematology in Seattle in1980 and was named a clinical research professor of the American Cancer Society in 1988. In 1989, he moved to New York City as president of the New York Blood Center and Director of its research institute. In 1998, he moved to Milwaukee as Executive Vice President for research at the Blood Center of Wisconsin and Director of its Blood Research Institute. Two years ago, he joined the faculty at the University of California, San Diego, as Clinical Professor of medicine in hematology/oncology. He is the author or co-author of more than 250 scientific articles and reviews.

Previous responsibilities include: Editor-in-chief of the journal Blood, founding editor of Current Opinion in Hematology, President of the American Society of Hematology and President of the Society for the Advancement of Blood Management. His clinical interests include the molecular biology of iron metabolism and the use of iron and erythropoietic stimulating agents in anemia management.

Professor Justo Medrano graduated in Medicine at the University of Seville (Spain) in 1963 and the University of Cologne (Germany), where he also did his post graduate training at the University Hospital. In 1972, he was named consultant at the University Hospital of Essen, under the direction of Professor F. W. Eigler, contributing to the development of the pioneer centre for organ transplant in Germany in the seventies. During this period he became Associate Professor of Surgery and coordinator of clinical teaching in surgery.

In 1978, Professor Medrano obtained Professorship at the University of Alicante, (Spain) and in 1990 he moved to the University Miguel Hernández, Elche.Since then he has also been Medical Director and Head of Department for Surgery at the University Hospitals of Elche and San Juan de Alicante. He has also held the position of the Dean of the Faculty of Medicine and Vice-chancellor for International Relations.

Professor Medrano’s professional life has been dedicated to both Education and Clinical Activity, constantly working towards the interaction of both. His main lines of research have been in digestive physiology and oncology, as well as in medical education. He is advisor and evaluator to ‘The Spanish Foundation for Research in Health’ (FIS).

As a surgeon, he has worked primarily on transplants, vascular surgery as well as digestive surgery. He has acted with particular concern for the quality of medical care and consequently has given emphasis to the appropriate indications of blood transfusion as an ethical obligation, advocating the need for further research about the limits of human tolerance in acute anemia. He has been a member of the Commission for Blood Transfusion at San Juan Hospital. In 1998, he presided the XXI International Seminar for Surgery in Alicante focusing on “Surgery without blood”, where he promoted this concept, by proposing that the number of transfusions per surgical intervention should be considered as a reference indicator of quality. He is one of the first surgeons in the south of Spain to support bloodless surgery as an ethical right for the Jehovah Witness community. Blood management defined today as a patient driven therapy that only uses blood or blood products as an ultimate solution was his practical concept in the nineties of the last century.

In the area of medical education, he has been a strong advocate of the educational reform programs, focusing on student centered learning and giving greater importance to teaching attitudes. In1996 he created the first Skill Lab in Spain for medical students. He has also been a pioneer of the interuniversity cooperation Project of the European Erasmus Program since its beginnings in 1989 and has been member of the Academic Advisory Group of the Erasmus Program in Brussels.

He has over 150 publications, most of them in peer reviewed journals, more than 200 scientific contributions to congresses based on his clinical work, he is also author of 5 books about surgery and has contributed to more than 50 chapters of text books. He has also organized numerous international seminars for both surgery and education. He is member of the German Association of Surgery, the Spanish Association of surgical oncology and others.

Professor Medrano is past President of the Valencian Society of Surgery, past President of the Valencian Society of Digestive Pathology, Vice -president of the National Deans Conference of Spain. He is also Academic member of the Royal Academy of Medicine of Valencia and of Spain.

At present he is President of the Commission of the new Faculty of Medicine of the University Jaume I in Castellón and member of the Senate of the Universidad Miguel Hernandez of Elche (Alicante) Spain.

James Isbister is a haematologist at Royal North Shore Hospital in Sydney and Clinical Professor of Medicine at the University of Sydney and adjunct professor, University of Technology, Sydney. Professor Isbister graduated from the University of NSW in 1968 and did his postgraduate training at St. Vincent’s Hospital, Sydney and the Royal Postgraduate Medical School in London. He has been at Royal North Shore Hospital since 1980, being head of the department of haematology and transfusion medicine from 1982-1996 and Director of Transfusion Medicine from 1997-2002. He is immediate past-president of the Australian and New Zealand Apheresis Association and was president of the 8th congress of the World Apheresis Association held in Perth in 2000. He is on the editorial board of Transfusion and Apheresis Science. He has a broad range of interests in haematology and transfusion medicine, especially in apheresis, haematological aspects of oxygen transport and complications of blood transfusion. He has a longstanding interest in teaching and is the author of three books on haematology and transfusion medicine and has contributed chapters to several major textbooks.

Qualifications:
BSc(Med) Hons 1965, MB BS Hons 1968, MRACP 1972, FRACP 1975, FRCPA 1977

Awards:
1999-2000 Bob Pitney Lecturer for the Haematology Society of Australia and New Zealand
2000 Carl De Gruchy Lecturer of the Haematology Society of Australia and New Zealand
2000 Peter Schiff award for contributions to Transfusion Medicine in Australia & New Zealand

Professor Konrad Messmer, MD, is the Chairman of the Institute for Surgical Research at the University of Munich. He is also the Editor-in-Chief of both the European Surgical Research Journal and the Progress in Applied Microcirculation Journal and an Associate Editor of Langenbeck’s Archives of Surgery. Dr. Messmer also is on the editorial board of several journals including Microvascular Research, Microcirculation, Shock, and the European Journal of Medical Research.

Professor Messmer has received more than a dozen international awards throughout his career and has presided over many medical and scientific congresses including the 6th World Congress for Microcirculation, the European Shock Society Congress and the European Society for Surgical Research Congress.

Michael Busch, MD

Dr. Busch is Director of Blood Systems Research Institute (BSRI) and Vice-President for Research and Scientific Affairs of Blood Systems, Inc. (BSI), a national network of over 30 blood centers throughout the United States. He is an Adjunct Professor of Laboratory Medicine at the University of California, San Francisco. Dr. Busch directs several national multi-center research studies, and his laboratory has an international reputation in the fields of viral safety and transfusion medicine, hosting visiting scholars from around the world. He has guided work in optimization and implementation of new nucleic amplification technology (NAT) for mass screening of blood donations for HIV, HCV, HBV and WNV. In addition, his laboratory holds several contracts for sample repositories and cell line development, for local studies and international projects. He has published over 200 original scientific articles and over 50 review articles and book chapters.

Steven Kleinman, MD

Dr. Kleinman is an internationally recognized expert in the field of blood safety.

Since 1996, he has been president of a transfusion medicine consulting company (Kleinman Biomedical Research) located in Victoria, BC whose clients include numerous blood collection organizations, government, and industry in both the US and Canada. He is also Clinical Professor of Pathology at U. British Columbia. He has published over 100 peer reviewed scientific articles and 18 book chapters and has co-edited a textbook in Transfusion Medicine. He has chaired the American Association of Blood Banks (AABB) Committee on Transfusion Transmitted Disease, the AABB Interagency Task Force on Bacterial Contamination of Platelets and the Consensus Panel of the 2004 Canadian Consensus Conference on TRALI.

SABM leadership selected the Honorable Horace Krever to receive the 2004 President’s Award. Following are the words Richard Spence, MD, SABM Board Member, used to introduce the Honorable Horace Krever.

Honorable Horace Krever,

The Society for the Advancement of Blood Management is truly honored to present you with the Society’s Presidential Award as a pioneer in blood management. Born in Montreal, Quebec, you were educated in the public school system of Toronto. You earned a degree in political science and economics from the University of Toronto followed by training in law at the University of Toronto, Osgoode Hall Law School. You were called to the bar in 1956 and received the accolades of Queen’s Court in 1970 and LLD (Queen’s) in 2002.

You engaged in the practice of both civil and criminal litigation in Toronto, while you also answered the call to teach future generations. You rose through the academic ranks to the level of Professor of Law at the University of Toronto and the University of Western Ontario. Your interest in health care and medico-legal interactions began early in your career. You have served as a member, Commissioner or Chair of no less than fifteen prestigious groups including serving as President to the Medico-Legal Society of Toronto and as a member of the Committee on Accreditation of Canadian Medical Schools.

In 1975, you were appointed Judge of the Supreme Court of Ontario High Court of Justice. In the early 1980’s, the recognition that the human immunodeficiency virus was transmitted by transfusion of blood products shook the foundations of the medical community. Our patients demanded that someone assume responsibility for the safety of the blood supply. Once again, you answered the call for Canada, first by co-chairing the Royal Society of Canada’s Projection on AIDS in 1987, then, serving as Head of the Royal Commission of Inquiry into the Blood System in Canada.

During this four year honorable effort, you listened to the tragic stories of victims, gathered and reviewed millions of documents, and heard testimony from international experts, all the while maintaining a scholarly, disciplined and compassionate process. Your recommendations changed the practice of blood management, not only in Canada, but throughout the world. Because of your efforts, patients have regained their confidence in our healthcare systems, evidence has begun to replace anecdote in transfusion practice and our organization, the Society for the Advancement of Blood Management now exists. You have earned our humble thanks and life-long appreciation.